[HTML][HTML] A systematic review and meta-analysis of sacubitril-valsartan in the treatment of ventricular remodeling in patients with heart failure after acute myocardial …

X Zhou, H Zhu, Y Zheng, X Tan, X Tong - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Objective: To systematically review the efficacy and safety of sacubitril-valsartan in the
treatment of acute myocardial infarction complicated with heart failure and to observe …

[HTML][HTML] Protective Effect of Combined Metoprolol and Atractylenolide I in Rats with Acute Myocardial Infarction via Modulation of the SIRT3/β-CATENIN/PPAR-γ …

W Zhou, J Liu, Z Sun, Y Dong, M Zhu… - Brazilian Journal of …, 2023 - SciELO Brasil
Herein, we examined the protective effect of metoprolol combined with atractylenolide I (Atr
I) in acute myocardial infarction (AMI) by regulating the SIRT3 (silent information regulator …

[PDF][PDF] 血清NT-proBNP, UA/Cr 联合检测对UAP 患者发生AMI 的预测价值

吴晶晶, 陈润祥, 廖占玲, 安国印, 郭洁 - 医学临床研究 - journal07.magtech.org.cn
[目的] 探讨不稳定型心绞痛(UAP) 患者血清氨基末端B 型脑钠肽前体(NT-proBNP),
尿酸(UA)/肌酐(Cr) 与冠心病严重程度的关系及对急性心肌梗死(AMI) 发病的预测价值.[方法] …

[PDF][PDF] Behandling med valsartan vid hjärtsvikt-En utvärdering av valsartan, sacubitril/valsartan effekt vid hjärtsvikt

N Koraish - 2022 - diva-portal.org
Metod: Detta arbete är en litteraturstudie baserad på fem original vetenskapliga artiklar togs
fram genom sökning i PubMed databas, en artikel togs från Web Of Science. Inriktningen var …